Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-060793

Chief Medical Officer sold 17,500 shares at an average $19.44 ($340,168)

  • Chief Medical Officer acquired 17,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2019-01-02 Option exercise +5,775 $5.28 $30,492 183,900 I: show line 1 in the form
Ho Carole Chief Medical Officer 2019-01-02 Sale −4,875 $19.43 $94,721 179,025 I: show line 2 in the form
Ho Carole Chief Medical Officer 2019-01-02 Sale −900 $20.24 $18,216 178,125 I: show line 3 in the form
Ho Carole Chief Medical Officer 2019-01-03 Option exercise +5,775 $5.28 $30,492 183,900 I: show line 4 in the form
Ho Carole Chief Medical Officer 2019-01-03 Sale −5,775 $18.90 $109,148 178,125 I: show line 5 in the form
Ho Carole Chief Medical Officer 2019-01-04 Option exercise +5,950 $5.28 $31,416 184,075 I: show line 6 in the form
Ho Carole Chief Medical Officer 2019-01-04 Sale −1,500 $19.30 $28,950 182,575 I: show line 7 in the form
Ho Carole Chief Medical Officer 2019-01-04 Sale −4,450 $20.03 $89,134 178,125 I: show line 8 in the form
Open-market sales · 17,500 sh · avg $19.44 · $340,168

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2019-01-02 Option exercise · Stock Option (right to buy) −5,775 78,600 D: show line 9 in the form
Ho Carole Chief Medical Officer 2019-01-03 Option exercise · Stock Option (right to buy) −5,775 72,825 D: show line 10 in the form
Ho Carole Chief Medical Officer 2019-01-04 Option exercise · Stock Option (right to buy) −5,950 66,875 D: show line 11 in the form
Loading xslF345X03/doc4a.xml…